The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dillon Michael P. since 2020.
This trader's CIK number is 1777415.
At the time of last reporting, Dillon Michael P. was the SVP, Chief Scientific Officer of Ideaya Biosciences, Inc.. (stock ticker symbol IDYA).
Also see all insider trading activities at Ideaya Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | IDYA | 0 | $0 | 61,000 | $1,476,612 | 41,000 | $281,511 |
| 2020 | IDYA | 0 | $0 | 0 | $0 | 7,750 | $33,402 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-10-04 | IDYA | Sale | 1,500 | 26.23 | 39,351 |
| 2021-10-04 | IDYA | Option Ex | 1,500 | 11.08 | 16,620 |
| 2021-09-08 | IDYA | Sale | 11,384 | 27.54 | 313,515 |
| 2021-09-07 | IDYA | Sale | 116 | 27.46 | 3,185 |
| 2021-09-08 | IDYA | Option Ex | 11,384 | 7.70 | 87,599 |
| 2021-09-07 | IDYA | Option Ex | 116 | 4.31 | 499 |
| 2021-09-02 | IDYA | Sale | 10,000 | 25.09 | 250,940 |
| 2021-08-09 | IDYA | Option Ex | 1,500 | 4.31 | 6,464 |
| 2021-08-09 | IDYA | Sale | 11,500 | 23.24 | 267,237 |
| 2021-07-27 | IDYA | Option Ex | 10,000 | 5.62 | 56,150 |
| 2021-07-27 | IDYA | Sale | 10,000 | 25.15 | 251,460 |
| 2021-07-06 | IDYA | Option Ex | 1,500 | 6.92 | 10,380 |
| 2021-07-06 | IDYA | Sale | 1,500 | 22.48 | 33,721 |
| 2021-06-17 | IDYA | Sale | 3,893 | 22.49 | 87,541 |
| 2021-06-16 | IDYA | Sale | 1,107 | 22.47 | 24,872 |
| 2021-06-17 | IDYA | Option Ex | 3,893 | 6.92 | 26,939 |
| 2021-06-16 | IDYA | Option Ex | 1,107 | 6.92 | 7,660 |
| 2021-05-11 | IDYA | Option Ex | 5,000 | 6.92 | 34,600 |
| 2021-05-11 | IDYA | Sale | 5,000 | 20.22 | 101,095 |
| 2021-02-09 | IDYA | Option Ex | 5,000 | 6.92 | 34,600 |
| 2021-02-09 | IDYA | Sale | 5,000 | 20.74 | 103,695 |
| 2020-12-18 | IDYA | Option Ex | 7,750 | 4.31 | 33,402 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dillon Michael P. (SVP, Chief Scientific Officer of Ideaya Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.